Glenmark Pharmaceuticals opens first U.S. manufacturing site

The India-based drugmaker invested more than $100 million into the Monroe, North Carolina facility that is designed to manufacture a variety of fixed dose pharmaceutical formulations

Source: PharmaManufacturing.com - October 30, 2018 Category: Pharmaceuticals Source Type: news